Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT02821988
Other study ID # 16-04574-XP
Secondary ID
Status Not yet recruiting
Phase N/A
First received June 24, 2016
Last updated June 29, 2016
Start date July 2016
Est. completion date May 2017

Study information

Verified date June 2016
Source University of Tennessee Health Science Center
Contact Laura Grese, MD
Phone 4235712990
Email lgrese@uthsc.edu
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

It is well established that obese women are at an increased risk of stillbirth compared to non obese women. This has led many physicians to begin antenatal testing in obese women in the third trimester through either nonstress tests or biophysical profiles. However, there is little evidence that antenatal testing improves fetal outcomes in obese women. The aim of this study is to determine if antenatal testing improves outcomes in obese women and to determine the optimal mode of testing (either nonstress tests or biophysical profiles).


Description:

1. Purpose: To determine if antenatal testing improves outcomes in obese pregnant women

2. Rationale: It has been well established that obese pregnant women are at increase risk of stillbirth compared to matched non obese controls. This relative risk is increased not only with increasing gestational age in obese women but with increasing severity of obesity. The increased risk of stillbirth has led some obstetricians to begin antenatal testing in obese women; however, there is little evidence that antenatal fetal surveillance improves outcomes.

3. Study/Project Population: Pregnant women before 32 weeks of gestation with an initial BMI >30kg/m2

4. Research Design: Randomized Controlled Trial

5. Study/Project Procedures: Patients will be randomized to one of three groups: daily kick counts only, nonstress test, amniotic fluid index, and daily kick counts, and biophysical profile and daily kick counts. These patients will be randomly assigned a group in a 1:1:1 ratio using a random number generator available online. Patients assigned to the daily kick counts only group will be called weekly to ensure they are doing daily kick counts. If they are noncompliant, they will be removed from the study and will undergo nonstress tests if they meet the initial BMI criteria as is the standard practice at our institution.

6. Outcomes Measured: Stillbirth, induction of labor, mode of delivery, neonatal intensive care unit admission, AGPARs <7 at 5 minutes of life


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 100
Est. completion date May 2017
Est. primary completion date May 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

less then 32 weeks gestation BMI > 30kg/m2 English speaking

Exclusion Criteria:

age < 18 age >45 medical comorbidity which requires antenatal testing other than obesity unwilling to consent Non-English speaking not pregnant Gestational age >32 weeks

Study Design

Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


Intervention

Device:
External fetal monitor for Nonstress test

Ultrasonography for Biophysical profile


Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
University of Tennessee Health Science Center Regional One Health

Outcome

Type Measure Description Time frame Safety issue
Primary Stillbirth demise of infant prior to delivery as verified by ultrasonography until delivery, up to 41 weeks No
Primary Mode of delivery whether the subject undergoes a vaginal delivery, cesarean delivery, or operative delivery will be recorded at delivery, up to 41 weeks No
Secondary Neonatal intensive care unit admission admission at delivery, up to 41 weeks No
Secondary Apgar score of less than 7 at 5 minutes at delivery, up to 41 weeks No
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03875300 - Best Start - Weight Management During Pregnancy N/A